Patent ID: 11939340
Assignee: PRELUDE THERAPEUTICS INCORPORATED
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 12:
13. The compound of claim 1, that is a compound of formula XVII, formula XVIII, formula XIX, formula XX, formula XXI, or formula XXII:, , or a pharmaceutically acceptable salt or solvate or N-oxide thereof; wherein
E is bond, C(Ra)2, NRa, —O—, —S—, SO, SO2, SO2NRa, —C(═O)NRa—, NaC(═O)NRa, or NRaS(O)2NRa;
R4 is H, D, Me, or haloalkyl; and
R6 is H, D, optional substituted C1-6 alkyl, optional substituted C3-6 cycloalkyl, or optional substituted C3-6 heterocycloalkyl.